Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Supplies from China stable for now, but monitoring situation: Novartis' Vas Narasimhan - The Hindu BusinessLine
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
The 'student' of leadership who seeks to inspire his employees | Financial Times
Novartis appointed Vasant Narasimhan as CEO, effective February 1, 2018
Novartis CEO On How Yoga & Lessons From His Grandparents Help In Taking Big Professional Decisions - YouTube
Vasant Narasimhan | Novartis
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Vasant Narasimhan - Wikipedia
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
Novartis global chief focuses on innovative medicines for Indian market
Vas Narasimhan | One Young World
Indian-origin CEOs take pride in identity': Novartis's Vas Narasimhan
/cloudfront-us-east-2.images.arcpublishing.com/reuters/AQ6AEJN4IJMKPDF4JS6QOCORLM.jpg "Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters")
Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube
Novartis' CEO is “un-bossing” his 125,000 employees
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis CEO's $50 Billion of Deals Was Just the First Act - Bloomberg
Can Novartis Digitally Transform Clinical Development? - TimmermanReport.com
Vas Narasimhan on the post-pandemic world - Novartis Live. Magazine
Novartis chief criticises EU move to control pharma licensing in emergencies | Financial Times
